Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China.
China Market Intelligence
Sanctions the United States May Deploy Against China August 5th, 2020
China Targets Financial Services, Cybersecurity, and IP in 2020 Legislative Work Plan August 5th, 2020
An Overview of China’s Ongoing IP Reforms August 5th, 2020
What to Expect When You Arrive in China July 22nd, 2020
China Provisions that Could Pass with the Annual NDAA July 22nd, 2020